CPIX
Price
$3.31
Change
-$0.35 (-9.56%)
Updated
Sep 5 closing price
Capitalization
49.52M
66 days until earnings call
HYPMY
Price
$4.21
Change
+$0.07 (+1.69%)
Updated
Sep 5 closing price
Capitalization
2.7B
Interact to see
Advertisement

CPIX vs HYPMY

Header iconCPIX vs HYPMY Comparison
Open Charts CPIX vs HYPMYBanner chart's image
Cumberland Pharmaceuticals
Price$3.31
Change-$0.35 (-9.56%)
Volume$52.93K
Capitalization49.52M
Hypera SA
Price$4.21
Change+$0.07 (+1.69%)
Volume$1.55K
Capitalization2.7B
CPIX vs HYPMY Comparison Chart in %
Loading...
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPIX vs. HYPMY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIX is a Hold and HYPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CPIX: $3.31 vs. HYPMY: $4.22)
Brand notoriety: CPIX and HYPMY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPIX: 76% vs. HYPMY: 1%
Market capitalization -- CPIX: $49.52M vs. HYPMY: $2.7B
CPIX [@Pharmaceuticals: Generic] is valued at $49.52M. HYPMY’s [@Pharmaceuticals: Generic] market capitalization is $2.7B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPIX’s FA Score shows that 0 FA rating(s) are green whileHYPMY’s FA Score has 2 green FA rating(s).

  • CPIX’s FA Score: 0 green, 5 red.
  • HYPMY’s FA Score: 2 green, 3 red.
According to our system of comparison, HYPMY is a better buy in the long-term than CPIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPIX’s TA Score shows that 4 TA indicator(s) are bullish while HYPMY’s TA Score has 4 bullish TA indicator(s).

  • CPIX’s TA Score: 4 bullish, 5 bearish.
  • HYPMY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HYPMY is a better buy in the short-term than CPIX.

Price Growth

CPIX (@Pharmaceuticals: Generic) experienced а -5.16% price change this week, while HYPMY (@Pharmaceuticals: Generic) price change was -0.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

CPIX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($2.7B) has a higher market cap than CPIX($49.5M). HYPMY YTD gains are higher at: 43.484 vs. CPIX (39.662). HYPMY has higher annual earnings (EBITDA): 1.41B vs. CPIX (3.49M). HYPMY has more cash in the bank: 1.2B vs. CPIX (16.1M). CPIX has less debt than HYPMY: CPIX (10.3M) vs HYPMY (8.86B). HYPMY has higher revenues than CPIX: HYPMY (6.66B) vs CPIX (42.1M).
CPIXHYPMYCPIX / HYPMY
Capitalization49.5M2.7B2%
EBITDA3.49M1.41B0%
Gain YTD39.66243.48491%
P/E RatioN/A19.64-
Revenue42.1M6.66B1%
Total Cash16.1M1.2B1%
Total Debt10.3M8.86B0%
FUNDAMENTALS RATINGS
CPIX vs HYPMY: Fundamental Ratings
CPIX
HYPMY
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9481
PRICE GROWTH RATING
1..100
5261
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (9) in the null industry is significantly better than the same rating for CPIX (100) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew significantly faster than CPIX’s over the last 12 months.

HYPMY's Profit vs Risk Rating (100) in the null industry is in the same range as CPIX (100) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew similarly to CPIX’s over the last 12 months.

HYPMY's SMR Rating (81) in the null industry is in the same range as CPIX (94) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew similarly to CPIX’s over the last 12 months.

CPIX's Price Growth Rating (52) in the Pharmaceuticals Other industry is in the same range as HYPMY (61) in the null industry. This means that CPIX’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's P/E Growth Rating (11) in the null industry is significantly better than the same rating for CPIX (100) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew significantly faster than CPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPIXHYPMY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
69%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 1 day ago
66%
Declines
ODDS (%)
Bearish Trend 27 days ago
79%
Bearish Trend 26 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLGZY12.19N/A
N/A
Flughafen Zuerich AG
VAIAF51.26N/A
N/A
Vaisala OY
SBNYL2.75N/A
N/A
Signature Bank (New York, NY)
RENEF12.12N/A
N/A
Cartesian Growth Corporation II
TBBA6.70-0.30
-4.29%
TEB Bancorp Inc.

CPIX and

Correlation & Price change

A.I.dvisor tells us that CPIX and QNTM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
-9.56%
QNTM - CPIX
26%
Poorly correlated
-1.64%
LFCR - CPIX
22%
Poorly correlated
-5.16%
ACB - CPIX
22%
Poorly correlated
+1.66%
SHOT - CPIX
22%
Poorly correlated
-3.13%
ELAN - CPIX
21%
Poorly correlated
+5.50%
More

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and PLNH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and PLNH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+1.57%
PLNH - HYPMY
21%
Poorly correlated
+10.91%
CPIX - HYPMY
20%
Poorly correlated
-9.56%
GLASF - HYPMY
20%
Poorly correlated
+3.99%
KMDA - HYPMY
20%
Poorly correlated
+1.13%
JUSHF - HYPMY
18%
Poorly correlated
+6.59%
More